Johnson K, De Ridder W, Topf A, et al. Extending the clinical and mutational spectrum of -related myopathies in a non-Hutterite population. J Neurol Neurosurg Psychiatry. 2019;90(4):490-493. doi:10.1136/jnnp-2018-318288
Renneville A, Boissel N, Nibourel O, et al. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia. 2012;26(6):1247-54. doi:10.1038/leu.2011.382
Genereux DP, Laird CD. At what rate do new premutation alleles arise at the fragile X locus? Hum Genet. 2013;132(6):715-7. doi:10.1007/s00439-013-1291-6
Yu M, Maden SK, Stachler M, et al. Subtypes of Barrett’s oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut. 2019;68(3):389-399. doi:10.1136/gutjnl-2017-314544
Hanna GJ, Kofman ER, Shazib MA, et al. Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors. Oral Oncol. 2018;81:1-9. doi:10.1016/j.oraloncology.2018.04.007
Di Gioia SA, Shaaban S, Tuysuz B, et al. Recessive MYF5 Mutations Cause External Ophthalmoplegia, Rib, and Vertebral Anomalies. Am J Hum Genet. 2018;103(1):115-124. doi:10.1016/j.ajhg.2018.05.003
Pacheco AR, Lazarus JE, Sit B, et al. CRISPR Screen Reveals that EHEC’s T3SS and Shiga Toxin Rely on Shared Host Factors for Infection. mBio. 2018;9(3). doi:10.1128/mBio.01003-18
Cohen KA, Stott KE, Munsamy V, Manson AL, Earl AM, Pym AS. Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2020;64(9). doi:10.1128/AAC.00860-20
Garvie CW, Wu X, Papanastasiou M, et al. Structure of PDE3A-SLFN12 complex reveals requirements for activation of SLFN12 RNase. Nat Commun. 2021;12(1):4375. doi:10.1038/s41467-021-24495-w
Awad MM, Liu S, Rybkin II, et al. Acquired Resistance to KRAS Inhibition in Cancer. N Engl J Med. 2021;384(25):2382-2393. doi:10.1056/NEJMoa2105281